Heart Valve Technology

This channel includes news and new device innovations about heart valve technologies, including the aortic valve, mitral valve, pulmonic valve, and tricuspid valve. This includes information on transcatheter valve technologies like transcatheter aortic valve replacement (TAVR, or implantation TAVI), transcatheter mitral valve repair or replacement (TMVR), transcatheter and surgical valve repairs, and surgical replacement valves. Newer devices are now being used for transcatheter tricuspid valve repair replacement (TTVR). 

Videos | Heart Valve Technology

Jay Mohan, D.O., RPVI, interventional cardiology fellow at William Beaumont Hospital, Royal Oak, Michigan, created this ...

Home June 10, 2020
Home
SMT (Sahajanand Medical Technology Private Ltd.), a leading medical device company of India focused on cardiology, announced it Hydra transcatheter aortic valve replacement (TAVR) device received European CE mark approval. It is indicated for the treatment of patients diagnosed with aortic stenosis. #SMT #HYDRA #TAVR
Feature | Heart Valve Technology

June 9, 2020 — SMT (Sahajanand Medical Technology Private Ltd.), a leading medical device company in India focused on ...

Home June 09, 2020
Home
News | Heart Valve Technology

June 8, 2020 — Edwards Lifesciences Corp. announced Chinese regulatory approval for the Edwards Sapien 3 transcatheter ...

Home June 08, 2020
Home
News | Structural Heart

May 29, 2020 — Neovasc Inc., developer of a minimally invasive transcatheter mitral valve replacement (TMVR) ...

Home May 29, 2020
Home
News | Congenital Heart

May 21, 2020 — Two late-breaking clinical trials on trans catheter valves to treat congenital heart disease were ...

Home May 21, 2020
Home
News | Heart Valve Technology

May 18, 2020 — The Edwards Lifesciences Corp. Pascal tricuspid transcatheter valve repair (TTVR) system received ...

Home May 18, 2020
Home
Key TAVR Takeaways From ACC 2020
Feature | Heart Valve Technology | Dave Fornell, Editor

Some U.S. centers need improvement in their outcomes was the biggest takeaway from the five transcatheter aortic valve ...

Home April 20, 2020
Home
Videos | Coronavirus (COVID-19)

Detroit, Michigan, has been one the hardest hit regions with a large number of COVID-19 cases. William O’Neill, M.D. ...

Home April 10, 2020
Home
The American College of Cardiology (ACC) released a list of the latest practice-changing presentations at the ACC.20 annual meeting March 28-30, 2020, in Chicago. This includes five late-breaking clinical trial (LBCT) sessions and three featured clinical research sessions. There also are two LBCT deep-dive sessions where the experts will break down the hottest trials and attendees can find out what the impact might be on the practice of cardiology and patients.
Feature | ACC | Dave Fornell, Editor

Here is the list of American College of Cardiology (ACC) practice-changing late-breaking study presentations at the ACC ...

Home April 09, 2020
Home
Abbott announced its TriClip Transcatheter Tricuspid Valve Repair (TTVR) System has received European CE mark clearance as a non-surgical treatment for people with a tricuspid valve regurgitation (TR). 
Feature | Heart Valve Technology

April 9, 2020 — Abbott announced its TriClip Transcatheter Tricuspid Valve Repair (TTVR) System has received European CE ...

Home April 09, 2020
Home
Videos | Structural Heart

Basel Ramlawi, M.D., chairman of The Heart and Vascular Center at Valley Health System in Virginia, director of the ...

Home April 03, 2020
Home
Videos | Structural Heart

A review of the PARTNER 3 Low-Risk Trial with Michael Mack, M.D., chairman, cardiovascular service line,  Baylor Scott ...

Home April 01, 2020
Home
News | Heart Valve Technology

March 30, 2020 — Edwards Lifesciences Corp. announced it is temporarily pausing new enrollments in its active pivotal ...

Home March 30, 2020
Home
News | Heart Valve Technology

March 30, 2020 — Patients in the United Kingdom (U.K.) who underwent transcatheter aortic valve replacement (TAVR) did ...

Home March 30, 2020
Home
Subscribe Now